Evidence map

ArticleScience (New York, N.Y.)2009

The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.

Chang-Liang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

109 papers cite itlatest 60 shown

2009
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 19644119